Home | Welcome to Contract Pharma   
Last Updated Saturday, April 25 2015

Print

Breaking News

April 24, 2015
Animal Health offsets lingering effects of patent expirations for Cymbalta and Evista  Read More »
April 24, 2015
Soliris sales up 6%  Read More »
April 24, 2015
BioScience business revenues up 2%  Read More »
April 24, 2015
Aims to increase efficiencies in trials with greater access to critical investigator and site data  Read More »
April 24, 2015
TECFIDERA revenues up 63%  Read More »
April 24, 2015
Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics  Read More »
April 24, 2015
Bruno to serve as CEO for Italian operating companies  Read More »
April 24, 2015
Product sales were up 13% in the quarter  Read More »
April 23, 2015
Will initiate a GLP toxicity study  Read More »
April 23, 2015
Initiates Phase III Trial  Read More »
April 23, 2015
Dako completes corrective actions following Warning Letter   Read More »
April 22, 2015
Combination would create an industry giant in the global generics space  Read More »
April 22, 2015
Expands advanced, aseptic, glass-free injectable platform  Read More »
April 22, 2015
Lab has more than doubled in size and will serves as a cGMP testing site  Read More »
April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On